Antitumor Activity of Orally Bioavailable Farnesyltransferase Inhibitor, ABT-100, Is Mediated by Antiproliferative, Proapoptotic, and Antiangiogenic Effects in Xenograft ModelsDebra C. Ferguson, Ingrid B.J. Joseph, Kenneth Jarvis et al.|Clinical Cancer Research|2005Cited by 22
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studiesWen‐Zhen Gu, Haiying Zhang, Ingrid B.J. Joseph et al.|Anti-Cancer Drugs|2005Cited by 7